Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriem Skander

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|September 30, 2005
Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacersMyriem Skander, Christophe Malan, Anita Ivanova, et al.
Organic Letters|April 21, 2009
Platinum(II) catalysts for highly enantioselective 1,6-enyne cycloisomerizations. synthetic, structural, and catalytic studiesDelphine Brissy, Myriem Skander, Hélène Jullien, et al.
The Journal of Organic Chemistry|October 8, 2005
New regiospecific synthesis of 2-trifluoromethyl-1,5 diazapentadiene compounds and of 2-trifluoromethylquinolines, their cyclization productsSalem El Kharrat, Myriem Skander, Abdelkader Dahmani, et al.
Journal of Medicinal Chemistry|February 13, 2010
N-heterocyclic carbene-amine Pt(II) complexes, a new chemical space for the development of platinum-based anticancer drugsMyriem Skander, Pascal Retailleau, Bernard Bourrié, et al.
Journal of the American Chemical Society|September 17, 2004
Artificial metalloenzymes for enantioselective catalysis based on biotin-avidinJérôme Collot, Julieta Gradinaru, Nicolas Humbert, et al.
Journal of the American Chemical Society|November 4, 2004
Artificial metalloenzymes: (strept)avidin as host for enantioselective hydrogenation by achiral biotinylated rhodium-diphosphine complexesMyriem Skander, Nicolas Humbert, Jérôme Collot, et al.
Journal of Medicinal Chemistry|May 16, 2023
Anti-Cancer and Radio-Sensitizing Properties of New Bimetallic (<i>N</i>-Heterocyclic Carbene)-Amine-Pt(II) ComplexesTao Jia, Oumar Diane, Deepanjan Ghosh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|September 30, 2005
Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacersMyriem Skander, Christophe Malan, Anita Ivanova, et al.
Organic Letters|April 21, 2009
Platinum(II) catalysts for highly enantioselective 1,6-enyne cycloisomerizations. synthetic, structural, and catalytic studiesDelphine Brissy, Myriem Skander, Hélène Jullien, et al.
The Journal of Organic Chemistry|October 8, 2005
New regiospecific synthesis of 2-trifluoromethyl-1,5 diazapentadiene compounds and of 2-trifluoromethylquinolines, their cyclization productsSalem El Kharrat, Myriem Skander, Abdelkader Dahmani, et al.
Journal of Medicinal Chemistry|February 13, 2010
N-heterocyclic carbene-amine Pt(II) complexes, a new chemical space for the development of platinum-based anticancer drugsMyriem Skander, Pascal Retailleau, Bernard Bourrié, et al.
Journal of the American Chemical Society|September 17, 2004
Artificial metalloenzymes for enantioselective catalysis based on biotin-avidinJérôme Collot, Julieta Gradinaru, Nicolas Humbert, et al.
Journal of the American Chemical Society|November 4, 2004
Artificial metalloenzymes: (strept)avidin as host for enantioselective hydrogenation by achiral biotinylated rhodium-diphosphine complexesMyriem Skander, Nicolas Humbert, Jérôme Collot, et al.
Journal of Medicinal Chemistry|May 16, 2023
Anti-Cancer and Radio-Sensitizing Properties of New Bimetallic (<i>N</i>-Heterocyclic Carbene)-Amine-Pt(II) ComplexesTao Jia, Oumar Diane, Deepanjan Ghosh, et al.
Pageof 1